COVID 19 in Children: Gastrointestinal, Hepatobiliary and Pancreatic Manifestation
- PMID: 33830145
COVID 19 in Children: Gastrointestinal, Hepatobiliary and Pancreatic Manifestation
Abstract
The most devastating pandemic of this era coronavirus disease-2019 (COVID-19) is caused by a novel virus named severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Although it is primarily a respiratory pathogen, it can also result in several extra-pulmonary manifestations includes gastrointestinal symptoms, hepatocellular injury. Angiotensin-converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 (TMPRSS2), the entry receptor for the causative coronavirus SARS-CoV-2 is co-express in the gastrointestinal tract, hepatocyte, and cholangiocytes similar to the respiratory mucosa. The presence of these receptors facilitates the entry into the tissue and causes direct viral tissue damage, which is a proposed mechanism of injury. Diarrhoea, nausea, vomiting, abdominal discomfort are common gastrointestinal manifestations, whereas derangement of liver function tests is the most hepatic manifestation in COVID-19. In this article, we reviewed on SARS-CoV-2 disease COVID-19 regarding gastrointestinal, hepatic, and pancreatic manifestation, the mechanisms by which the virus may inflict damage, and their management perspective.
Similar articles
-
Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children.Indian Pediatr. 2020 Jun 15;57(6):533-535. doi: 10.1007/s13312-020-1851-5. Indian Pediatr. 2020. PMID: 32562397 Free PMC article.
-
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579. World J Gastroenterol. 2020. PMID: 32884218 Free PMC article. Review.
-
Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19.J Clin Virol. 2020 Jul;128:104386. doi: 10.1016/j.jcv.2020.104386. Epub 2020 Apr 29. J Clin Virol. 2020. PMID: 32388469 Free PMC article. Review.
-
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839. Mikrobiyol Bul. 2020. PMID: 32755524 Review. Turkish.
-
Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management.World J Gastroenterol. 2021 Jul 28;27(28):4504-4535. doi: 10.3748/wjg.v27.i28.4504. World J Gastroenterol. 2021. PMID: 34366621 Free PMC article. Review.
Cited by
-
The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity?Biomedicines. 2021 Jun 23;9(7):710. doi: 10.3390/biomedicines9070710. Biomedicines. 2021. PMID: 34201505 Free PMC article. Review.
-
Traditional Chinese Medicine in Treating Children With Coronavirus Disease 2019: A Scoping Review.Front Pediatr. 2022 Jul 19;10:935551. doi: 10.3389/fped.2022.935551. eCollection 2022. Front Pediatr. 2022. PMID: 35928680 Free PMC article.
-
Exploring the phytochemicals of Platycodon grandiflorus for TMPRSS2 inhibition in the search for SARS-CoV-2 entry inhibitors.J King Saud Univ Sci. 2022 Aug;34(6):102155. doi: 10.1016/j.jksus.2022.102155. Epub 2022 Jun 9. J King Saud Univ Sci. 2022. PMID: 35702062 Free PMC article.
-
Proteolysis and Deficiency of α1-Proteinase Inhibitor in SARS-CoV-2 Infection.Biochem Mosc Suppl B Biomed Chem. 2022;16(4):271-291. doi: 10.1134/S1990750822040035. Epub 2022 Nov 16. Biochem Mosc Suppl B Biomed Chem. 2022. PMID: 36407837 Free PMC article.
-
Commentary on COVID-19-induced liver injury in various age and risk groups.World J Virol. 2023 Jan 25;12(1):44-52. doi: 10.5501/wjv.v12.i1.44. World J Virol. 2023. PMID: 36743662 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical
Miscellaneous